Condition

Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 2 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials2

Recruiting0

Common interventions8

Lead sponsors shown2

Clinical trials

2 shown

Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic MalignanciesNCT01273766 · 2011-01-01

COMPLETED

Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without CancerNCT00112593 · 1999-11-01

COMPLETED

Common interventions

laboratory biomarker analysisOTHER2 cyclosporineDRUG1 deferasiroxDRUG1 enzyme-linked immunosorbent assayOTHER1 fludarabine phosphateDRUG1 mycophenolate mofetilDRUG1 peripheral blood stem cell transplantationPROCEDURE1 total-body irradiationRADIATION1

Leading sponsors

Fred Hutchinson Cancer Center 1 Wake Forest University Health Sciences 1

Trial status mix

COMPLETED2

Phase mix

NA1

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.